Contemporary immunosuppression in renal transplant recipients: one size does not fit all
- 1 February 1999
- journal article
- review article
- Published by Elsevier in Transplantation Proceedings
- Vol. 31 (1-2) , 254-255
- https://doi.org/10.1016/s0041-1345(98)01524-3
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Induction therapy with rabbit antithymocyte sera reduces rejection episodes in immunologically low-risk living donor renal transplant recipientsTransplantation Proceedings, 1997
- MULTICENTER RANDOMIZED TRIAL COMPARING TACROLIMUS (FK506) AND CYCLOSPORINE IN THE PREVENTION OF RENAL ALLOGRAFT REJECTION1Transplantation, 1997
- A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1997
- Use of cyclosporine pharmacokinetic profiles in an antibody induction protocol reduces early acute rejection rates in recipients of primary cadaveric renal allograftsTransplantation Proceedings, 1997
- MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1997
- MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1995
- A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MONOCLONAL ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY (BT563) ADMINISTRATION TO PREVENT ACUTE REJECTION AFTER KIDNEY TRANSPLANTATIONTransplantation, 1995
- Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejectionThe Lancet, 1995
- Antilymphocyte Globulin Versus OKT3 Induction Therapy in Cadaveric Kidney Transplantation: A Prospective Randomized StudyAmerican Journal of Kidney Diseases, 1992
- ANTILYMPHOBLAST GLOBULIN, CYCLOSPORINE, AND STEROIDS IN CADAVERIC RENAL TRANSPLANTATIONTransplantation, 1990